Tempus AI Selected By Advanced Research Projects Agency For Health To Be Awarded $9.5M For First Autonomous Clinical AI Agent
Tempus AI, Inc. (NASDAQ: TEM) today announced that it has been selected by the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, to receive an
Tempus AI won a $9.5 million grant from a U.S. government health agency to build a new kind of AI that can help doctors on its own. This shows that important people think Tempus's AI ideas are good and worth trying, which is a positive sign for the company.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.